Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Putative new childhood leukemia cancer predisposition syndrome caused by germline bi-allelic missense mutations in DDX41

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Blocking protein quality control to counter hereditary cancers

    Research output: Contribution to journalReviewResearchpeer-review

  3. Novel fusion genes and chimeric transcripts in ependymal tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The molecular profile of mucosal melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Management of Asparaginase Toxicity in AYAs with ALL

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Expanding the cerebrovascular phenotype of the p.R258H variant in ACTA2 related hereditary thoracic aortic disease (HTAD)

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

DDX41 has recently been identified as a new autosomal dominantly inherited cancer predisposition syndrome causing increased risk of adult onset acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). We report for the first time compound heterozygote germline missense DDX41 mutations located in the DEAD-box domain, identified in two siblings by exome sequencing. Both siblings have slight dysmorphic findings, psychomotor delays and intellectual disability, and one developed blastic plasmacytoid dendritic cell neoplasm (BPDCN) at age five. RNA-sequencing of bone marrow showed DDX41 expression including both mutations. However, the allele fraction of p.Pro321Leu accounted for 96% in the RNA-sequencing indicating this mutation to be the more significant variant. Exome sequencing of the leukemic blasts identified no additional known driver mutations. There is no pattern indicating autosomal dominantly inherited cancer predisposition in the family, but the father has sarcoidosis, which has been associated with heterozygous DDX41 mutation. We propose that bi-allelic mutations in DDX41 could potentially be a new cancer predisposition syndrome associated with delayed psychomotor development. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalGenes, Chromosomes & Cancer
Volume57
Issue number12
Pages (from-to)670-674
ISSN1045-2257
DOIs
Publication statusPublished - 2018

ID: 55414731